Clinical Trial Update: Heart Failure and Anemia [Phase 2]

View source ↗

Summary

Amgen reports completion of a Phase 2 trial evaluating a therapy for heart failure and anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Heart Failure

Snippet

Sponsor: Amgen | Conditions: Heart Failure, Anemia | Phase 2 | Status: COMPLETED